The state of New York has made significant progress when it comes to marijuana reform, becoming the 23rd state in the union to legalize medical marijuana. However, the state has been criticized for limitations on its policies, and advocates are working for further progress.
Recreational Marijuana in New York
Recreational marijuana remains illegal in New York. Possession of small amounts of marijuana, fewer than 25 grams, has been decriminalized in New York since the 70’s and is punishable by fines of $100 to $250. Possession of 25 grams to 8 oz. is still considered a misdemeanor in the state and punishable by 3 months incarceration and a maximum fine of $500. Possession of more than 8 oz. is a felony and punishable by jail time of 4 to 15 years and fines of $5,000 to $15,000.
Medical Marijuana in New York
The State of New York did legalize medical marijuana in 2014 with the passing of the Compassionate Care Act (Assembly Bill 6357). Patients must obtain a certification for medical marijuana from a physician that is registered with the Medical Marijuana Program. Under the law, registered patients with a qualifying condition have access to a 30-day supply of non-smokable marijuana products, including capsules, liquids and oil for vaporization or administration via inhaler. Home cultivation of marijuana for medical purposes is not permitted under the law. There are currently 20 open and operating dispensaries throughout the state.
In New York, the following conditions are approved for medical marijuana access:
- Amyotrophic Lateral Sclerosis (ALS)
- Chronic Pain (added December 1, 2016)
- HIV / AIDS
- Huntington’s Disease
- Inflammatory Bowel Disease
- Multiple Sclerosis
- Parkinson’s Disease
- Spinal Cord Damage Causing Spasticity
The Department of Health commissioner is charged with to adding or removing qualifying conditions. The department has previously considered and refused to add Alzheimer’s disease, muscular dystrophy, dystonia, post-traumatic stress disorder (PTSD), and rheumatoid arthritis.
As of January 24, 2017, there are 12,764 patients certified by practitioners and 833 physicians that have registered for the NYS Medical Marijuana Program.
This medical marijuana policy has come under scrutiny for a few reasons, including the exclusion of certain conditions from qualifying and the exclusion of smokable marijuana.
CBD Hemp Oil in New York
Consumption of CBD hemp oil is federally legal, as CBD hemp oil falls under the same importation and commerce laws as other hemp products. New York has not enacted legislation specifically relating to CBD hemp oil, so it is legal to purchase and consume.
Cultivation of Cannabis in New York
The personal cultivation of cannabis for personal or medical use remains illegal. Five licensed producers provide the supply of cannabis for New York’s medical marijuana program.
New York State did pass Senate Bill 7047 in 2014 to legalize the cultivation of industrial hemp for research purposes. Growers must be certified and approved by the Department of Agriculture and Markets. Up to 10 additional sites, authorized by the commissioner, can be approved for growth and cultivation of hemp.
DISCLAIMER: The information contained in this website is for general information purposes only; it does not constitute legal advice. Although we endeavor to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Therefore, any reliance you place on such information is strictly at your own risk.
This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.